|

Upper Extremity Rehabilitation With Virtual Reality in Parkinson's Disease Patients

RECRUITINGN/ASponsored by Ramazan KURUL
Actively Recruiting
PhaseN/A
SponsorRamazan KURUL
Started2023-11-01
Est. completion2025-11-01
Eligibility
Healthy vol.Accepted

Summary

Upper extremities are the first part of the body to be affected by Parkinson's disease. Although studies have shown that virtual reality-assisted rehabilitation methods are effective on gait and balance, studies on their use for upper extremity rehabilitation are limited. For this reason, the aim of the project is to examine whether virtual reality supported upper extremity position matching exercises, which will be specially prepared according to joint ranges of motion, will provide functional improvement in the upper extremities of individuals with Parkinson's disease.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Accepting to participate in the research
* Being diagnosed with Parkinson's Disease by a neurologist
* Continuing anti-parkinsonian medication
* Hoehn-Yahr (H-Y) stage 3 and below
* Ability to walk independently
* To have full range of motion in shoulder abduction and elbow extension movements

Exclusion Criteria:

* Presence of additional neurological diseases other than Parkinson's Disease
* Scores below 21 on the Montreal Cognitive Assessment Scale
* Change in medication dosage in the last 1 month
* Severe visual impairment or complete hearing impairment in both ears
* Having a rheumatologic, musculoskeletal, etc. disease that may affect upper extremity functions
* The occurrence of severe tremors or dyskinesias due to the end of the drug dose
* Failing the Titmus butterfly test

Conditions5

Neurological RehabilitationParkinson DiseaseParkinson's DiseaseUpper Extremity DysfunctionVirtual Reality

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.